Wegovy is now the first weight-loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight, says John Sharretts, MD, director of the division of diabetes, lipid disorders, and obesity in the FDAs Center for Drug Evaluation and Research, in a release
This can depend on if youre breastfeeding
Clinical data shows that most patients experience some weight regain after stopping GLP-1 therapy which is why our maintenance protocols and long-term support are built into every program from day one

Why 50mg is the standard vial size Common GHK-Cu vial sizes: 50mg (most popular) 100mg (economy size) 200mg (bulk) 10mg, 20mg (smaller, less common) Why 50mg is ideal: Perfect for 5-10 week protocol Lasts 25-50 doses (depending on dose used) Not too expensive (most 50mg vials $80-150) Easy reconstitution math Reasonable commitment (test if it works for you) Fits standard protocols Cost per dose from 50mg: If vial costs $100 Gives 25 doses at 2mg each = $4 per dose Very affordable for anti-aging Injectable vs topical GHK-Cu Injectable (most powerful): Systemic effects throughout body 80-90% bioavailability Works on skin from inside out Dose: 1-3mg, 3-7x weekly Best for comprehensive anti-aging Topical (easiest): Applied to skin surface Lower absorption (1-2% concentration in serum) Works locally on skin Daily application Best for focused skin improvement Can combine with injectable Which to choose: Injectable: Serious anti-aging, whole-body benefits Topical: Easier, good for skin-only goals Both: Maximum results See our copper peptides GHK-Cu guide , glow peptides guide , glow peptides , and injectable vs oral peptides

Start your intake How GLP-1 Medications May Increase Urinary Tract Infection Risk GLP-1 receptor agonists like semaglutide slow gastric emptying and reduce appetite, which can lead to decreased fluid intake when patients are not intentionally hydrating
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus